Basic Information | Post buying leads | Suppliers | Cas Database |
Conditions | Yield |
---|---|
With hydrogen; closo-3,3-(η2,η3-C7H7CH2)-3,1,2-RhC2B9H11 In methanol at 43℃; under 76000 Torr; for 4h; | A 95.5% B 2% |
With hydrogen; rhodium-carborane complex B In methanol at 100℃; under 76000 Torr; for 4h; | A 41% B 52.5% |
With hydrogen; In methanol at 60℃; under 76000 Torr; for 4h; | A 96 % Chromat. B 2.5 % Chromat. |
With hydrogen; In methanol at 60℃; under 76000 Torr; for 4h; Yield given. Yields of byproduct given; | |
With hydrogen; closo-(ϖ-cyclodienyl)rhodacarborane In methanol at 60℃; under 76000 Torr; for 4h; Product distribution; various catalyst; | A 96 % Chromat. B 2.5 % Chromat. |
doxycycline
Conditions | Yield |
---|---|
With hydrogen; palladium In tetrahydrofuran; methanol at 23℃; under 760.051 Torr; for 2h; |
doxycycline hydrochloride
doxycycline
Conditions | Yield |
---|---|
With sodium hydroxide In water at 90℃; |
doxycycline
Conditions | Yield |
---|---|
With palladium on activated charcoal; hydrogen In methanol; water at 45 - 65℃; under 2625.26 - 3375.34 Torr; Pressure; Inert atmosphere; |
doxycycline
doxycycline hydrochloride
Conditions | Yield |
---|---|
With hydrogenchloride In methanol; water | 90% |
Conditions | Yield |
---|---|
With N-iodo-succinimide at 20℃; for 5h; | 80% |
doxycycline
Conditions | Yield |
---|---|
With mercury(II) diacetate In N,N-dimethyl-formamide at 20℃; for 6h; Molecular sieve; | 76% |
doxycycline
doxycycline-5-nitrate
Conditions | Yield |
---|---|
With acetic anhydride; copper(II) nitrate In tetrahydrofuran at -10 - 20℃; for 5h; | 44% |
With acetic anhydride; copper(II) nitrate In tetrahydrofuran at 20℃; for 2h; | 44% |
bis-(2-nitryloxy-ethyl)-amine
doxycycline
acetaldehyde
amido-N-[bis-(β-nitrooxyethyl)aminoethyl]-α-6-deoxy-5-oxytetracycline
Conditions | Yield |
---|---|
In tetrahydrofuran for 4h; Inert atmosphere; Reflux; | 35% |
In tetrahydrofuran for 4h; Reflux; Inert atmosphere; | 35% |
formaldehyd
doxycycline
4-nitrooxypiperidine
amido-N-[4-nitrooxypiperidinomethyl]-α-6-deoxy-5-oxytetracycline
Conditions | Yield |
---|---|
In tetrahydrofuran for 4h; Inert atmosphere; Reflux; | 32% |
In tetrahydrofuran for 4h; Reflux; Inert atmosphere; | 32% |
EPA Genetic Toxicology Program.
The IUPAC name of Doxycycline is (2Z,4S,4aR,5S,5aR,6R,12aS)-2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione. With the CAS registry number 564-25-0, it is also named as 5-Hydroxy-alpha-6-deoxytetracycline. The product's categories are Fungicide; Intermediates & Fine Chemicals; Pharmaceuticals, and the other registry numbers are 10597-92-9; 7164-70-7; 7264-10-0. Besides, it is yellow solid, which should be stored in . In addition, its molecular formula is C22H24N2O8 and molecular weight is 444.44.
The other characteristics of this product can be summarized as: (1)EINECS: 209-271-1; (2)ACD/LogP: 1.36; (3)# of Rule of 5 Violations: 2; (4)ACD/LogD (pH 5.5): 0.08; (5)ACD/LogD (pH 7.4): -1.53; (6)ACD/BCF (pH 5.5): 1; (7)ACD/BCF (pH 7.4): 1; (8)ACD/KOC (pH 5.5): 6.82; (9)ACD/KOC (pH 7.4): 1; (10)#H bond acceptors: 10; (11)#H bond donors: 7; (12)#Freely Rotating Bonds: 7; (13)Index of Refraction: 1.737; (14)Molar Refractivity: 109.03 cm3; (15)Molar Volume: 271.1 cm3; (16)Surface Tension: 99.2 dyne/cm; (17)Density: 1.63 g/cm3; (18)Flash Point: 368.2 °C; (19)Melting Point: 206-209°C; (20)Enthalpy of Vaporization: 105.53 kJ/mol; (21)Boiling Point: 685.2 °C at 760 mmHg; (22)Vapour Pressure: 1.03E-19 mmHg at 25 °C; (23)Water Solubility: 630 mg/L at 25 °C.
Uses of : this chemical is often used for the treatment of chronic prostatitis, sinusitis, syphilis, chlamydia, pelvic inflammatory disease, acne, rosacea, and Rickettsial infections. It is also used in prophylaxis against malaria. Moreover, it can be used in the treatment and prophylaxis of Bacillus anthracis. And it can be used to treat Lyme disease and Yersinia pestis. Besides, this product has been used to reduce transmission of the disease by killing the symbiotic Wolbachia bacteria. It is an inhibitor of matrix metalloproteases used in various experimental systems for this purpose at subantimicrobial doses.
People can use the following data to convert to the molecule structure.
(1)SMILES: O=C3/C(=C(/O)N)C(=O)[C@@]4(O)C(=O)\C2=C(/O)c1c(cccc1O)[C@@H]([C@H]2[C@H](O)[C@H]4[C@@H]3N(C)C)C
(2)InChI: InChI=1/C22H24N2O8/c1-7-8-5-4-6-9(25)11(8)16(26)12-10(7)17(27)14-15(24(2)3)18(28)13(21(23)31)20(30)22(14,32)19(12)29/h4-7,10,14-15,17,25-27,31-32H,23H2,1-3H3/b21-13-/t7-,10+,14+,15-,17-,22-/m0/s1
(3)InChIKey: UEVKMCOZLJYVNG-NMMSOKQRBG
The toxicity data is as follows:
Organism | Test Type | Route | Reported Dose (Normalized Dose) | Effect | Source |
---|---|---|---|---|---|
dog | LD50 | intravenous | > 100mg/kg (100mg/kg) | Pharmacological and Biochemical Properties of Drug Substances. Vol. 2, Pg. 305, 1979. | |
dog | LD50 | oral | > 500mg/kg (500mg/kg) | Pharmacological and Biochemical Properties of Drug Substances. Vol. 2, Pg. 305, 1979. | |
mouse | LD50 | intraperitoneal | 410mg/kg (410mg/kg) | Giornale Italiano di Chemioterapia. Italian Journal of Chemotherapy. Vol. 17, Pg. 276, 1970. | |
mouse | LD50 | intravenous | 241mg/kg (241mg/kg) | Pharmacological and Biochemical Properties of Drug Substances. Vol. 2, Pg. 305, 1979. | |
mouse | LD50 | oral | 1870mg/kg (1870mg/kg) | Giornale Italiano di Chemioterapia. Italian Journal of Chemotherapy. Vol. 17, Pg. 276, 1970. | |
rat | LD50 | intraperitoneal | 378mg/kg (378mg/kg) | Therapie. Vol. 23, Pg. 575, 1968. | |
rat | LD50 | intravenous | 228mg/kg (228mg/kg) | Pharmacological and Biochemical Properties of Drug Substances. Vol. 2, Pg. 305, 1979. | |
rat | LD50 | oral | > 2gm/kg (2000mg/kg) | Pharmacological and Biochemical Properties of Drug Substances. Vol. 2, Pg. 305, 1979. | |
women | TDLo | oral | 68mg/kg/24D-I (68mg/kg) | MUSCULOSKELETAL: JOINTS | Postgraduate Medical Journal. Vol. 67, Pg. 313, 1991. |